Announcement

Collapse
No announcement yet.

RaphaLX

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Kayleigh
    replied
    So far, a small pilot study has been carried out.

    Although the results are of limited value, they are promising enough for further trials to take place (as explained under the heading 'Conclusions') ...

    http://https://www.newbiotic.com/news-blog/results-of-an-open-label-prospective-trial-of-raphalx-probiotic-compound-in-als-patients

    Best wishes
    Kayleigh
    Last edited by Kayleigh; 5 February 2020, 16:18.

    Leave a comment:


  • nunhead_man
    replied
    Good morning Timm

    I looked in because Rapha is a cycling brand in the UK!

    This looks like another route to reduce glutamate and I guess this is to be welcomed but I can't see any clinical trial data.

    Perhaps somebody else will come along in a minute with that information?

    Leave a comment:


  • Timm
    started a topic RaphaLX

    RaphaLX

    do you have knowledge about this investigational drug - RaphaLX.

    https://www.newbiotic.com/about-raphalx

    they seem pretty confident in this drug

    " RaphaLXâ„¢ is the company's flagship product that has been granted Orphan Drug Designation (ODD) by the FDA to treat ALS (amyotropic lateral sclerosis). It is a breakthrough formulation derived from human gut bacteria (microbiome), which in human studies has been observed to slow down the progression of the disease and in certain cases reverse the condition"

    and I found this :

    https://survivalsewj.com/wp-content/...1-20-2020-.pdf
Working...
X